Literature DB >> 18560028

The role of SOCS-3 protein in leptin resistance and obesity.

Adisaputra Ramadhinara Lubis1, Fina Widia, Sidartawan Soegondo, Arini Setiawati.   

Abstract

Obesity is one of the risk factors in various chronic diseases and malignancy. It may result from excess accumulation of body fat. This condition may be caused by dysfunction of appetite-regulating pathways and energy balance due to leptin resistance. Leptin, a 16 kDa hormone, is the most important regulator of appetite and energy balance in the body. Most individuals with obesity have leptin resistance characterized by increased leptin blood levels. Some possibilities of mechanism involved in leptin resistance have been proposed by researchers despite the fact that it is still being studied hitherto. One of the mechanisms considered to have a role in leptin resistance is disruption in signal transduction process through Janus-activating kinase2-signal transducer and activator of transcription 3 (JAK2-STAT3) pathway on leptin receptors by suppressor of cytokine signaling-3 (SOCS-3). SOCS-3 is a protein that inhibits the signal transduction process of various cytokines in the body, including leptin. SOCS-3 expression is induced by leptin and SOCS-3 activation will inhibit STAT3 phosphorylation which is important in signal transmission on leptin receptors. Such inhibition will consequently cause leptin resistance characterized by dysfunction of leptin biological function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18560028

Source DB:  PubMed          Journal:  Acta Med Indones        ISSN: 0125-9326


  21 in total

Review 1.  Oxidative stress and inflammation interactions in human obesity.

Authors:  Isabel Bondia-Pons; Lisa Ryan; J Alfredo Martinez
Journal:  J Physiol Biochem       Date:  2012-02-17       Impact factor: 4.158

2.  Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphic.

Authors:  Sonali Shaligram; Farjana Akther; Md Rahatullah Razan; James L Graham; Núria Roglans; Marta Alegret; Arta Gharib Parsa; Kimber L Stanhope; Peter J Havel; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2020-04-19       Impact factor: 4.432

3.  Suppressor of cytokine signaling 3 inhibits LPS-induced IL-6 expression in osteoblasts by suppressing CCAAT/enhancer-binding protein {beta} activity.

Authors:  Chunguang Yan; Jay Cao; Min Wu; Wei Zhang; Tao Jiang; Aihiko Yoshimura; Hongwei Gao
Journal:  J Biol Chem       Date:  2010-09-28       Impact factor: 5.157

4.  Suppressor of cytokine signaling-3 is a glucagon-inducible inhibitor of PKA activity and gluconeogenic gene expression in hepatocytes.

Authors:  Allison M Gaudy; Alicia H Clementi; Jean S Campbell; Alan V Smrcka; Robert A Mooney
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

5.  RLIP76 protein knockdown attenuates obesity due to a high-fat diet.

Authors:  Sharad S Singhal; James Figarola; Jyotsana Singhal; Marpadga A Reddy; Xueli Liu; David Berz; Rama Natarajan; Sanjay Awasthi
Journal:  J Biol Chem       Date:  2013-07-02       Impact factor: 5.157

6.  Inactivation of TNF/LT locus alters mouse metabolic response to concentrated ambient PM2.5.

Authors:  Ziying Hu; Minjie Chen; Huifen Zhou; Anui Tharakan; Xiaoke Wang; Lianglin Qiu; Shuai Liang; Xiaobo Qin; Yuhao Zhang; Wanjun Wang; Yanyi Xu; Zhekang Ying
Journal:  Toxicology       Date:  2017-09-14       Impact factor: 4.221

7.  Upregulation of suppressor of cytokine signaling 3 ameliorates spinal degenerative disease in adolescents by mediating leptin and tumor necrosis factor-α levels.

Authors:  Xiao-Ming Tang; Jian Dai; Hai-Lang Sun
Journal:  Exp Ther Med       Date:  2019-07-17       Impact factor: 2.447

8.  Hepatitis C virus E2 protein involve in insulin resistance through an impairment of Akt/PKB and GSK3β signaling in hepatocytes.

Authors:  Ming-Ju Hsieh; Kuang-Ping Lan; Hao-Yu Liu; Xiao-Zong Zhang; Yaw-Feng Lin; Tzy-Yen Chen; Hui-Ling Chiou
Journal:  BMC Gastroenterol       Date:  2012-06-21       Impact factor: 3.067

Review 9.  Pathobiological and molecular connections involved in the high fructose and high fat diet induced diabetes associated nonalcoholic fatty liver disease.

Authors:  Manisha Gupta; Amarjot Kaur; Thakur Gurjeet Singh; Onkar Bedi
Journal:  Inflamm Res       Date:  2020-06-23       Impact factor: 6.986

Review 10.  Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.

Authors:  Felipe Correa-da-Silva; Eric Fliers; Dick F Swaab; Chun-Xia Yi
Journal:  J Neuroendocrinol       Date:  2021-06-22       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.